Translational predictions of phase 2a first-in patient efficacy studies for antituberculosis drugs https://www.biorxiv.org/content/10.1101/2023.01.18.524608v1?med=mas
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.